颌面部血管瘤患者应用平阳霉素加地塞米松治疗的临床效果

Clinical Effect of Pingyangmycin and Dexamethasone in Treatment of Maxillofacial Hemangioma

目的：分析平阳霉素联合地塞米松治疗颌面部血管瘤的临床效果。方法：将收治的100例颌面部血管瘤患者按照随机分配表的方式平均分为观察组和对照组，每组50例患者。观察组给予平阳霉素联合地塞米松治疗，对照组仅给予地塞米松治疗，比较2组患者临床治疗的有效率和不良反应的发生率。结果：观察组经过治疗后，临床治疗的总有效率明显高于对照组，具有统计学意义（P＜0．05）；观察组的不良反应发生率明显低于对照组，具有统计学意义（P＜0．05）。结论：平阳霉素联合地塞米松治疗颌面部血管瘤的临床效果优于单纯应用平阳霉素治疗颌面部血管瘤的临床效果，并且不良反应发生率低，建议广泛使用。

Objective：To analyze the clinical effect of pingyangmycin and dexamethasone in treatment of maxillofacial hemangioma. Methods：100 cases with maxillofacial hemangioma were divided equally into observation group and control group, 50 cases in each group. Observation group received the treatment of pingyangmycin and dexamethasone, control group only received the treatment of dexametha-sone.Compare the therapeutic efficiency and adverse reaction rate. Results：After treatment, total effective rate of observation group was obviously higher than control group, and it was statistically significant （P〈0.05）.The adverse reaction rate of observation group was ob-viously lower than control group, and it was statistically significant（P〈0.05）.Conclusion：The clinical effect of pingyangmycin and dexa-methasone is better than only dexamethasone in treatment of maxillofacial hemangioma. The adverse reaction rate is lower and it is worthy of wide use.